FDA Fifth Biannual Progress Report on Judicious Use of Antimicrobials in Food-producing Animals In December 2013, the agency took a significant step forward in addressing antimicrobial resistance by publishing Guidance #213, which calls on animal drug sponsors of approved medically important antimicrobials administered to food-producing animals through medicated feed or water to remove from their product labels indications for use related to growth promotion, and to bring the remaining therapeutic uses of these products under the oversight of a veterinarian by the end of December 2016. All of the affected drug sponsors have committed in writing to making the changes described in the guidance by the end of 2016. The FDA fully expects this process to be completed by this deadline. |